company background image
UCM logo

Uscom CHIA:UCM Stock Report

Last Price

AU$0.031

Market Cap

AU$6.8m

7D

0%

1Y

0%

Updated

06 Apr, 2025

Data

Company Financials

Uscom Limited

CHIA:UCM Stock Report

Market Cap: AU$6.8m

UCM Stock Overview

Designs, develops, manufactures, and markets non-invasive cardiovascular and pulmonary medical devices in Australia, Asia, the Americas, and Europe. More details

UCM fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health5/6
Dividends0/6

Risk Analysis

Shares are highly illiquid

Does not have a meaningful market cap (A$7M)

Earnings have declined by 16.5% per year over past 5 years

Does not have meaningful revenue (A$4M)


Community vs My Fair Value

Select a narrative for quick price alerts from the community, or create your own.

Uscom Limited Competitors

Control Bionics

ASX:CBL

AU$10.3m

HeraMED

ASX:HMD

AU$14.0m

InhaleRx

ASX:IRX

AU$5.3m

dorsaVi

ASX:DVL

AU$5.1m

Price History & Performance

Summary of share price highs, lows and changes for Uscom
Historical stock prices
Current Share PriceAU$0.031
52 Week HighAU$0.034
52 Week LowAU$0.012
Beta-1.22
1 Month Change0%
3 Month Changen/a
1 Year Change0%
3 Year Change-65.56%
5 Year Change-89.84%
Change since IPO-84.50%

Recent News & Updates

Recent updates

Shareholder Returns

UCMAU Medical EquipmentAU Market
7D0%1.5%1.8%
1Y0%-13.4%1.6%

Return vs Industry: UCM exceeded the Australian Medical Equipment industry which returned -15% over the past year.

Return vs Market: UCM exceeded the Australian Market which returned -3.7% over the past year.

Price Volatility

Is UCM's price volatile compared to industry and market?
UCM volatility
UCM Average Weekly Movementn/a
Medical Equipment Industry Average Movement11.7%
Market Average Movement9.3%
10% most volatile stocks in AU Market16.8%
10% least volatile stocks in AU Market4.1%

Stable Share Price: UCM's share price has been volatile over the past 3 months compared to the Australian market.

Volatility Over Time: Insufficient data to determine UCM's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
1999n/aRob Phillipswww.uscom.com.au

Uscom Limited designs, develops, manufactures, and markets non-invasive cardiovascular and pulmonary medical devices in Australia, Asia, the Americas, and Europe. It offers USCOM 1A, a non-invasive hemodynamic monitor that measures blood flow, stroke volume, and cardiac output; and BP+, a supra-systolic oscillometric central blood pressure monitor that measures blood pressure and blood pressure waveforms at the heart, as well as in the arm. The company also provides the SpiroSonic Ultrasonic spirometer, a pulmonary function testing device that uses multi-path ultrasound; SpiroSonic FLO and SpiroSonic AIR, a digital multi-path ultrasonic spirometer for pulmonary function diagnostic and monitoring COPD and asthma; and SpiroSonic SMART for use by general practitioners and patients for screening COPD and asthma.

Uscom Limited Fundamentals Summary

How do Uscom's earnings and revenue compare to its market cap?
UCM fundamental statistics
Market capAU$6.76m
Earnings (TTM)-AU$2.36m
Revenue (TTM)AU$3.63m

1.9x

P/S Ratio

-2.9x

P/E Ratio

Is UCM overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
UCM income statement (TTM)
RevenueAU$3.63m
Cost of RevenueAU$595.61k
Gross ProfitAU$3.04m
Other ExpensesAU$5.40m
Earnings-AU$2.36m

Last Reported Earnings

Dec 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-0.0094
Gross Margin83.60%
Net Profit Margin-65.07%
Debt/Equity Ratio54.2%

How did UCM perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/04/06 00:09
End of Day Share Price 2025/01/07 00:00
Earnings2024/12/31
Annual Earnings2024/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Uscom Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.